Literature DB >> 11474033

Serological differentiation of experimentally induced Candida dubliniensis and Candida albicans infections.

M D Moragues1, M J Omaetxebarria, N Elguezabal, J Bikandi, G Quindós, D C Coleman, J Pontón.   

Abstract

Using a rabbit model of systemic infection, we show that it is possible to differentiate infections caused by Candida dubliniensis and other Candida species by detecting the antibody response mounted by the infected animals. These results confirm our previous observation in a patient with C. dubliniensis candidemia and suggest that detection of C. dubliniensis-specific antibodies is useful in the diagnosis of invasive candidiasis caused by this yeast.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11474033      PMCID： PMC88280          DOI： 10.1128/JCM.39.8.2999-3001.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  Candida dubliniensis: An update.

Authors:  D J Sullivan; G Moran; S Donnelly; S Gee; E Pinjon; B McCartan; D B Shanley; D C Coleman
Journal:  Rev Iberoam Micol       Date:  1999-06       Impact factor: 1.044

2.  Detection of antibodies to Candida albicans germ tubes during experimental infections by different Candida species.

Authors:  J Bikandi; R San Millán; P Regúlez; M D Moragues; G Quindós; J Pontón
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

3.  Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel.

Authors:  I Polacheck; J Strahilevitz; D Sullivan; S Donnelly; I F Salkin; D C Coleman
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.

Authors:  G P Moran; D J Sullivan; M C Henman; C E McCreary; B J Harrington; D B Shanley; D C Coleman
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

5.  Isolation of C. dubliniensis from insulin-using diabetes mellitus patients.

Authors:  A M Willis; W A Coulter; D J Sullivan; D C Coleman; J R Hayes; P M Bell; P J Lamey
Journal:  J Oral Pathol Med       Date:  2000-02       Impact factor: 4.253

6.  Specific antibody response in a patient with Candida dubliniensis fungemia.

Authors:  R Salesa; M D Moragues; R Sota; J Pemán; G Quindós; J Pontón
Journal:  Rev Iberoam Micol       Date:  2001-03       Impact factor: 1.044

7.  Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes.

Authors:  J Bikandi; R S Millán; M D Moragues; G Cebas; M Clarke; D C Coleman; D J Sullivan; G Quindós; J Pontón
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation.

Authors:  J F Meis; M Ruhnke; B E De Pauw; F C Odds; W Siegert; P E Verweij
Journal:  Emerg Infect Dis       Date:  1999 Jan-Feb       Impact factor: 6.883

9.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

10.  Candida dubliniensis fungemia: the first four cases in North America.

Authors:  M E Brandt; L H Harrison; M Pass; A N Sofair; S Huie; R K Li; C J Morrison; D W Warnock; R A Hajjeh
Journal:  Emerg Infect Dis       Date:  2000 Jan-Feb       Impact factor: 6.883
View more
  2 in total

1.  Differentiation of Candida albicans and Candida dubliniensis by using recombinant human antibody single-chain variable fragments specific for hyphae.

Authors:  Joseph M Bliss; Mark A Sullivan; Jane Malone; Constantine G Haidaris
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

2.  Tracking the amphibian pathogens Batrachochytrium dendrobatidis and Batrachochytrium salamandrivorans using a highly specific monoclonal antibody and lateral-flow technology.

Authors:  Michael J Dillon; Andrew E Bowkett; Michael J Bungard; Katie M Beckman; Michelle F O'Brien; Kieran Bates; Matthew C Fisher; Jamie R Stevens; Christopher R Thornton
Journal:  Microb Biotechnol       Date:  2016-12-19       Impact factor: 5.813
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.